Skip to content

Chendi Zhao

2 papers in the library · publishing 2026

Papers

Sort Most recent Most cited

Effect of Esketamine Pretreatment on Necroptosis in Mice with Trigeminal Neuralgia and Anxiety-Like Behavior via the RIP1/RIP3/MLKL Pathway.

Cellular and molecular neurobiology July 28, 2026 Rui Dong, Yuan Tian, Chendi Zhao et al.

To explore the effect of esketamine (ES) pretreatment on necroptosis in mice with trigeminal neuralgia accompanied by anxiety-like behavior and its correlation with the RIP1/RIP3/MLKL signaling pathway. Thirty male C57BL/6J mice were randomized into five groups (n=6): Control, Sham, model group (PIONT), PIONT+NS, and PIONT+ES. Trigeminal neuralgia model was established by left infraorbital...

DOI: 10.1007/s10571-026-01782-y (opens in new tab) Full text (opens in new tab) Anxiety-like behavior Esketamine pretreatment Necroptosis Rip1/rip3/mlkl pathway +1

Neuroprotective Effects of Esketamine in Central Nervous System Disorders: Mechanisms and Cellular Targets

Basic & Clinical Pharmacology & Toxicology March 11, 2026 Chendi Zhao, Yang Wang, Jinglang Wu et al.

Esketamine (ESK), the dextrorotatory enantiomer of ketamine, is an antagonist of the N-methyl-D-aspartic acid (NMDA) receptor. ESK is considered an effective anesthetic because of its ability to mitigate postoperative pain and opioid use. Recently, it has attracted significant research attention for its fast-acting antidepressant effects. Given the advantages of ESK in both perioperative and...

DOI: 10.1111/bcpt.70221 (opens in new tab) Ketamine Neuroprotection Central nervous system Pharmacology +9